Related Experiment Videos
Novel diarylsulphide derivatives as potential cytotoxic agents
H I el-Subbagh1, M A el-Sherbeny, M N Nasr
1Department of Medicinal chemistry, Faculty of Pharmacy, University of Mansoura, Egypt.
Bollettino Chimico Farmaceutico
|February 1, 1995
Summary
New diarylsulphide compounds were synthesized and tested for antimicrobial and cytotoxic effects. Several compounds demonstrated significant biological activity, warranting further investigation into their therapeutic potential.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Pharmacology
Background:
- Diarylsulphides represent a class of organic compounds with diverse biological activities.
- Exploring novel chemical structures is crucial for identifying new therapeutic agents.
- Antimicrobial resistance and the need for effective cytotoxic agents necessitate continuous research.
Purpose of the Study:
- To synthesize a novel series of diarylsulphide derivatives.
- To evaluate the synthesized compounds for their antimicrobial properties against various pathogens.
- To assess the cytotoxic potential of these compounds against selected cancer cell lines.
Main Methods:
- Synthesis of diarylsulphide compounds incorporating amino, acetamido, sulphonamido, benzamido, or arylideneamino functionalities.
- In vitro antimicrobial susceptibility testing using standard microbiological assays.
- Cytotoxicity evaluation employing established cell-based assays.
Main Results:
- Successful synthesis of a library of diarylsulphide derivatives.
- Identification of specific compounds exhibiting potent antimicrobial activity.
- Observation of significant cytotoxic effects in certain synthesized molecules.
- Correlation between structural features and observed biological activities.
Conclusions:
- The synthesized diarylsulphide derivatives show promise as potential antimicrobial and cytotoxic agents.
- Further research is warranted to optimize lead compounds and elucidate their mechanisms of action.
- This study contributes novel chemical entities for drug discovery efforts in infectious diseases and oncology.